REVIEW ARTICLE
Arrhythmogenic right ventricular cardiomyopathy
Carol Gemayel, MD*,
Antonio Pelliccia, MD and
Paul D. Thompson, MD, FACC*,*
* Hartford Hospital, Division of Cardiology, Hartford, Connecticut, USA
Institute of Sports Science, Rome, Italy
Manuscript received February 21, 2001;
revised manuscript received August 21, 2001,
accepted August 31, 2001.
* Reprint requests and correspondence: Dr. Paul D. Thompson, Division of Cardiology, Hartford Hospital, 80 Seymour Street, Hartford, Connecticut 06102 USA pthomps{at}harthosp.org
Arrythmogenic right ventricular (RV) cardiomyopathy (ARVC) is a cardiomyopathy characterized pathologically by fibrofatty replacement primarily of the RV and clinically by life-threatening ventricular arrhythmias in apparently healthy young people. The prevalence of the disease has been estimated at 1 in 5,000 individuals, although this estimate will likely increase as awareness of the condition increases among physicians. Arrythmogenic RV cardiomyopathy is recognized as a cause of sudden death during athletic activity because of its association with ventricular arrhythmias that are provoked by exercise-induced catecholamine discharge. Diagnosis may be difficult because many of the electrocardiographic abnormalities mimic patterns seen in normal children, and the disease often involves only patchy areas of the RV. For this reason, international diagnostic criteria for ARVC were proposed by an expert consensus panel in 1996. Treatment is directed to preventing life-threatening cardiac arrhythmias with medications and the use of implantable defibrillators. This article will present in detail the etiology, clinical presentation, diagnosis and management of this condition.
|
Abbreviations and Acronyms
| | ARVC | = arrhythmogenic right ventricular cardiomyopathy | | CHF | = congestive heart failure | | CT | = computerized tomography | | ECG | = electrocardiogram | | ICD | = implantable cardioverter defibrillator | | LV | = left ventricle or left ventricular | | MRI | = magnetic resonance imaging | | NSVT | = nonsustained ventricular tachycardia | | PVC | = premature ventricular complex | | RBBB | = right bundle branch block | | RV | = right ventricle or right ventricular | | RVOT | = right ventricular outflow tachycardia | | VT | = ventricular tachycardia |
|
This article has been cited by other articles:

|
 |

|
 |
 
F. Djouadi, Y. Lecarpentier, J.-L. Hebert, P. Charron, J. Bastin, and C. Coirault
A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy
Cardiovasc Res,
July 1, 2009;
(2009)
cvp183v2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Koplan and W. G. Stevenson
Ventricular Tachycardia and Sudden Cardiac Death
Mayo Clin. Proc.,
March 1, 2009;
84(3):
289 - 297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gilljam and C.-H. Bergh
Right ventricular cardiomyopathy: timing of heart transplantation in Uhl's anomaly and arrythmogenic right ventricular cardiomyopathy
Eur J Heart Fail,
January 1, 2009;
11(1):
106 - 109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Padera Jr. and F. J. Schoen
Pathology of Cardiac Surgery
Card. Surg. Adult,
January 1, 2008;
3(2008):
111 - 178.
[Full Text]
|
 |
|

|
 |

|
 |
 
J.G. Coghlan and J. Davar
How should we assess right ventricular function in 2008?
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H22 - H28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Myerburg and V. L. Vetter
Electrocardiograms Should Be Included in Preparticipation Screening of Athletes
Circulation,
November 27, 2007;
116(22):
2616 - 2626.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Stephenson and C. I. Berul
Electrophysiological Interventions for Inherited Arrhythmia Syndromes
Circulation,
August 28, 2007;
116(9):
1062 - 1080.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Nijveldt, A. M. Beek, T. Germans, O. Bondarenko, and A. C. van Rossum
Arrhythmogenic right ventricular cardiomyopathy with evidence of biventricular involvement
Can. Med. Assoc. J.,
June 19, 2007;
176(13):
1819 - 1821.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Marietta Clewing, B. C Antalfy, T. Lucke, B. Najafian, K. M Marwedel, A. Hori, R. M Powel, A F Safo Do, L. Najera, K. SantaCruz, et al.
Schimke immuno-osseous dysplasia: a clinicopathological correlation
J. Med. Genet.,
February 1, 2007;
44(2):
122 - 130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Thompson and B. D. Levine
Protecting Athletes From Sudden Cardiac Death
JAMA,
October 4, 2006;
296(13):
1648 - 1650.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
e247 - e346.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace,
September 1, 2006;
8(9):
746 - 837.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nemes, W. B. Vletter, M. F. Scholten, and F. J. ten Cate
Contrast echocardiography for perfusion in right ventricular cardiomyopathy
Eur J Echocardiogr,
December 1, 2005;
6(6):
470 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chimenti, M. Pieroni, A. Maseri, and A. Frustaci
Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia
J. Am. Coll. Cardiol.,
June 16, 2004;
43(12):
2305 - 2313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Motta, E. Mossad, and R. Savage
Right Ventricular Exclusion Surgery for Arrhythmogenic Right Ventricular Dysplasia with Cardiomyopathy
Anesth. Analg.,
June 1, 2003;
96(6):
1598 - 1602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kottkamp and G. Hindricks
Right ventricular tachycardia--arrhythmogenic right ventricular cardiomyopathy or idiopathic?
Eur. Heart J.,
May 1, 2003;
24(9):
787 - 788.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Aviram, J. E. Fishman, M.-L. Young, E. Redha, G. Biliciler-Denktas, and M. M. Rodriguez
MR Evaluation of Arrhythmogenic Right Ventricular Cardiomyopathy in Pediatric Patients
Am. J. Roentgenol.,
April 1, 2003;
180(4):
1135 - 1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Schoen and R. F. Padera Jr.
Cardiac Surgical Pathology
Card. Surg. Adult,
January 1, 2003;
2(2003):
119 - 185.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Scoote and A. J Williams
The cardiac ryanodine receptor (calcium release channel): Emerging role in heart failure and arrhythmia pathogenesis
Cardiovasc Res,
December 1, 2002;
56(3):
359 - 372.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|